Public Health

Low-dose aspirin review says no for CVD prevention in over 60s

The US Preventive Services Taskforce is recommending against initiating low-dose aspirin for the primary prevention of CVD in adults aged 60 years or older. And the Task Force is lukewarm on the benefit in younger people 40-59 years even with a 10% or greater 10-year CV risk based on the ACC/AHA risk calculator. “The USPSTF ...

Already a member?

Login to keep reading.

© 2021 the limbic